Immunomagnetic-Electrochemiluminescent Detection of Bacillus anthracis Spores in Soil Matrices.

Applied and Environmental Microbiology
J G Bruno, H Yu

Abstract

Rapid (<=1.5-h) detection of anthrax spores in soil suspensions was accomplished by an immunomagnetic electrochemiluminescence method. Strain-dependent detection limits in the range of 10(sup2) to 10(sup5) spores were achieved in buffer. The rank order of sensitivity for the assay in buffer was Sterne > Ames > Vollum 1B. Detection was up to 3 orders of magnitude less sensitive in soil suspensions, and the rank order of sensitivity was altered.

References

Jan 1, 1980·Annals of the New York Academy of Sciences·P S Brachman
Nov 18, 1994·Science·M MeselsonO Yampolskaya

❮ Previous
Next ❯

Citations

Aug 17, 2004·Clinical Chemistry·Jennifer BrigatiValery A Petrenko
Aug 4, 2009·Applied and Environmental Microbiology·Amanda B HerzogSyed A Hashsham
Apr 7, 2010·Applied and Environmental Microbiology·Shahar RotemAmram Mor
Jan 6, 2012·Journal of Fluorescence·John G Bruno, Maria P Carrillo
Nov 12, 2005·Analytical and Bioanalytical Chemistry·Katie A EdwardsAntje J Baeumner
Jul 10, 2012·Applied and Environmental Microbiology·Nathalie MorelChristophe Créminon
Jan 21, 2012·Applied Microbiology and Biotechnology·Léonid M Irenge, Jean-Luc Gala
Jun 18, 2016·Health Security·Norman A DoggettSegaran Pillai
Jun 10, 2004·Chemical Reviews·Mark M Richter
May 1, 1997·Applied and Environmental Microbiology·M R Blake, B C Weimer
Nov 16, 2005·Analytical Chemistry·Kathryn A J BorthwickW Terence Coakley
Apr 28, 2009·Journal of Microbiological Methods·Jason E DoverSang-Jin Suh

❮ Previous
Next ❯

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.